TP53 and neoplasm: Given that human pluripotent stem cells (hPSCs) have become an attractive source for regenerative therapies and the critical role of p53 in tumor suppression, careful genetic characterization of hPSCs and their derivatives should be carried out before clinical use (Merkle et al., 2017).